Strategies for liver injury caused by hepatocellular carcinoma targeted therapy
10.3760/cma.j.cn501113-20230905-00090
- VernacularTitle:肝癌靶向治疗导致肝损伤的应对策略
- Author:
Suxian ZHAO
1
;
Shiheng LIU
;
Yuemin NAN
Author Information
1. 河北医科大学第三医院中西医结合肝病科 河北省慢性肝病肝纤维化研究重点实验室 河北省国际科技合作基地——河北省肝癌分子诊断国际联合研究中心，石家庄 050051
- Keywords:
Hepatocellular carcinoma;
Targeted therapy;
Drug-induced liver injury
- From:
Chinese Journal of Hepatology
2023;31(11):1129-1132
- CountryChina
- Language:Chinese
-
Abstract:
Primary hepatocellular carcinoma has a high degree of malignancy, insidious onset, and rapid progression that seriously threatens human life and health. With the continuous deepening of the study of the molecular characteristics of tumors, molecular targeted drugs have become an important treatment method for patients with advanced liver cancer. Liver injury is one of the common adverse reactions of targeted drugs, which needs to be paid attention to. This paper mainly briefly expounds on the occurrence condition, mechanism, risk factors, diagnosis, and treatment of liver injury caused by hepatocellular carcinoma targeted therapy in order to provide a reference for the safe clinical application of targeted drugs.
